a slight trendP = 0.147
50.0%, P = 0.022), but the LS/NEX group merely showed a slight trend in the increasing risk of sepsis (25.0% vs. 39.6%, P = 0.147) ( Table 9 ).
50.0%, P = 0.022), but the LS/NEX group merely showed a slight trend in the increasing risk of sepsis (25.0% vs. 39.6%, P = 0.147) ( Table 9 ).
The difference in dosage requirement between SS/NEX and LS/EX groups at 12th month failed to reach statistical significance probably because of more than 1/3 of recipients having converted into a cyclosporine-based regimen in the LS/EX group. 3.4.